Overview

A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas

Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study evaluated the effect of capecitabine and concomitant radiation therapy in children with newly diagnosed brainstem gliomas.
Phase:
Phase 2
Details
Lead Sponsor:
Hoffmann-La Roche
Collaborator:
Pediatric Brain Tumor Consortium
Treatments:
Capecitabine